AAAna Luisa Bagno de Almeida

Ana Luisa Bagno de Almeida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Luisa Bagno de Almeida has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Alisson Pugliesi

    Departamento de Reumatologia, Universidade Estadual de Campinas, Campinas, Brazil

    1 shared publication
  • Ana Paula Monteiro Gomides Reis

    Departamento de Reumatologia, Universidade de Brasília, Brasília, Brazil

    1 shared publication
  • Claiton Viegas Brenol

    Departamento de Reumatologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

    1 shared publication
  • Eliane Viana Mancuzo

    Federal University of Minas Gerais, Belo Horizonte, Brazil

    1 shared publication
  • Geraldo da Rocha Castelar-Pinheiro

    Departamento de Reumatologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    1 shared publication
  • Gláucio Ricardo Werner de Castro

    Departamento de Reumatologia, Universidade do Sul de Santa Catarina-Unisul, Florianópolis, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of screening methods for preclinical interstitial lung disease associat-ed with rheumatoid arthritis

    by Ana Luisa Bagno de Almeida1, Mariana Drummond Martins Lima1, Maria Fernanda B. Resende Guimarães1, Eliane Viana Mancuzo1

  • Open Access

    Predictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort

    by Ana Luisa Bagno de Almeida, Maria Fernanda B. Resende Guimarães, Maria Raquel da Costa Pinto, Leticia Rocha Pereira, Ana Paula Monteiro Gomides Reis, Karina Rossi Bonfiglioli, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgi, Gláucio Ricardo Werner de Castro, Sebastião Cezar Radominski, et al.

    Background: Infections increase mortality and morbidity and often limit immunosuppressive treatment in rheumatoid arthritis patients. Objective: To analyze the occurrence of serious infections and the associated factors in a cohort of rheumatoid arthritis patients under real-life conditions. Methods: We analyzed data from the REAL, a prospective observational study, that evaluated Brazilian RA patients, with clinical and laboratory data collected over a year. Univariate and multivariate analyses were performed from the adjustment of the logistic regression model Generalized Estimating Equations (GEE), with the primary outcome being the occurrence of serious infection, defined as need for hospitalization or use of intravenous antibiotics for its treatment. Results: 841 patients were included with an average follow-up time of 11.2 months (SD 2.4). Eighty-nine serious infections occurred, corresponding to 13 infections per 100 patient-years. Pulmonary fibrosis, chronic kidney disease (CKD) and central nervous system disease increased the chances of serious infection by 3.2 times (95% CI: 1.5–6.9), 3.6 times (95% CI: 1.2–10.4) and 2.4 times (95% CI: 1.2–5.0), respectively. The use of corticosteroids in moderate doses increased the chances by 5.4 times (95% CI: 2.3–12.4), and for each increase of 1 unit in the health assessment questionnaire (HAQ), the chance increased 60% (95% CI: 20–120%). Conclusion: The use of corticosteroids at moderate doses increased the risk of serious infection in RA patients. Reduced functionality assessed by the HAQ and comorbidities were other important factors associated with serious infection in this cohort.